HHS and CMS Implement MFN Drug Pricing Model Following Executive Order
HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.
HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.